NASDAQ:FCSC - Fibrocell Science News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.47 +0.06 (+2.49 %)
(As of 04/26/2019 10:24 AM ET)
Previous Close$2.41
Today's Range$2.42 - $2.47
52-Week Range$1.45 - $5.17
Volume400 shs
Average Volume800,800 shs
Market Capitalization$24.10 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59

Headlines

Fibrocell Science (NASDAQ FCSC) News Headlines

Source:
DateHeadline
Is Fibrocell Science (FCSC) Stock Outpacing Its Medical Peers This Year?Is Fibrocell Science (FCSC) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - April 25 at 7:16 PM
Fibrocells Latest Partnership Provides A Leg Up For Gene Therapy ProductsFibrocell's Latest Partnership Provides A Leg Up For Gene Therapy Products
seekingalpha.com - April 24 at 6:37 PM
These 2 Biotech Stocks Are No Longer Off the RadarThese 2 Biotech Stocks Are No Longer 'Off the Radar'
finance.yahoo.com - April 17 at 7:27 PM
Fibrocell up 51% premarket on Castle Creek collaborationFibrocell up 51% premarket on Castle Creek collaboration
seekingalpha.com - April 15 at 7:24 PM
Fibrocell signs $135M deal to advance therapy for butterfly childrenFibrocell signs $135M deal to advance therapy for 'butterfly children'
www.bizjournals.com - April 15 at 7:24 PM
Fibrocell signs $135M deal to advance therapy for 'butterfly children'Fibrocell signs $135M deal to advance therapy for 'butterfly children'
finance.yahoo.com - April 15 at 7:24 PM
Fibrocell Strikes Funding Deal For Gene Therapy CandidateFibrocell Strikes Funding Deal For Gene Therapy Candidate
feeds.benzinga.com - April 15 at 2:37 PM
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyFibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
finance.yahoo.com - April 15 at 6:58 AM
Fibrocell Science Inc (FCSC) Sees Significant Increase in Short InterestFibrocell Science Inc (FCSC) Sees Significant Increase in Short Interest
www.americanbankingnews.com - April 13 at 3:16 AM
-$0.37 Earnings Per Share Expected for Fibrocell Science Inc (FCSC) This Quarter-$0.37 Earnings Per Share Expected for Fibrocell Science Inc (FCSC) This Quarter
www.americanbankingnews.com - April 4 at 7:37 PM
Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsFibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors
finance.yahoo.com - April 3 at 8:20 AM
Fibrocell Science Inc.Fibrocell Science Inc.
www.barrons.com - March 27 at 7:48 PM
Fibrocell Science, Inc. (FCSC) CEO John Maslowski on Q4 2018 Results - Earnings Call TranscriptFibrocell Science, Inc. (FCSC) CEO John Maslowski on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 27 at 7:48 PM
Fibrocell down 18% premarket on updated FCX-007 dataFibrocell down 18% premarket on updated FCX-007 data
seekingalpha.com - March 27 at 8:27 AM
Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
finance.yahoo.com - March 27 at 8:26 AM
Fibrocell up 15% ahead of key data readoutFibrocell up 15% ahead of key data readout
seekingalpha.com - March 20 at 10:48 PM
Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
finance.yahoo.com - March 20 at 8:16 AM
Fibrocell Science IncFibrocell Science Inc
www.bloomberg.com - March 18 at 8:01 PM
Fibrocell to Present at 21st Annual BIO CEO & Investor ConferenceFibrocell to Present at 21st Annual BIO CEO & Investor Conference
finance.yahoo.com - February 6 at 8:24 AM
What To Expect From Fibrocell Sciences Upcoming Data ReadoutWhat To Expect From Fibrocell Science's Upcoming Data Readout
seekingalpha.com - January 17 at 7:24 PM
Fibrocell to Present at Phacilitate Leaders World 2019Fibrocell to Present at Phacilitate Leaders World 2019
finance.yahoo.com - January 16 at 8:20 AM
Form 8-K Fibrocell Science, Inc. For: Jan 08 - StreetInsider.comForm 8-K Fibrocell Science, Inc. For: Jan 08 - StreetInsider.com
www.streetinsider.com - January 10 at 6:05 PM
Form SC 13G/A Fibrocell Science, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G/A Fibrocell Science, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - January 5 at 8:18 AM
Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research FoundationFibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
finance.yahoo.com - December 11 at 8:45 AM
What Kind Of Shareholders Own Fibrocell Science Inc (NASDAQ:FCSC)?What Kind Of Shareholders Own Fibrocell Science Inc (NASDAQ:FCSC)?
finance.yahoo.com - December 4 at 5:38 PM
Fibrocell Reports Third Quarter 2018 Financial Results and Recent HighlightsFibrocell Reports Third Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - November 13 at 8:16 AM
Fibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent HighlightsFibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - November 8 at 8:20 AM
Fibrocell Science (FCSC) Receives FDA Guidance on Phase 3 Clinical Trial Design for FCX-007Fibrocell Science (FCSC) Receives FDA Guidance on Phase 3 Clinical Trial Design for FCX-007
www.streetinsider.com - October 26 at 5:33 PM
Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007
finance.yahoo.com - October 25 at 8:20 AM
Fibrocell to Present at Upcoming Industry and Investor ConferencesFibrocell to Present at Upcoming Industry and Investor Conferences
finance.yahoo.com - September 26 at 8:26 AM
Fibrocell Science (FCSC) Secures $1.4M FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic ...Fibrocell Science (FCSC) Secures $1.4M FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic ...
www.streetinsider.com - September 25 at 4:59 PM
Form 8-K Fibrocell Science, Inc. For: Sep 25Form 8-K Fibrocell Science, Inc. For: Sep 25
www.streetinsider.com - September 25 at 4:59 PM
Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaFibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
finance.yahoo.com - September 25 at 8:14 AM
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized SclerodermaFibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
finance.yahoo.com - September 5 at 8:22 AM
Fibrocell Science, Inc. (FCSC) CEO John Maslowski on Q2 2018 Results - Earnings Call TranscriptFibrocell Science, Inc. (FCSC) CEO John Maslowski on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 6:02 PM
Fibrocell Reports Second Quarter 2018 Financial Results and Recent HighlightsFibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - August 9 at 8:26 AM
Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent HighlightsFibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - August 2 at 8:19 AM
Fibrocell Science: An Underappreciated Gene Therapy PlayFibrocell Science: An Underappreciated Gene Therapy Play
seekingalpha.com - July 27 at 5:22 PM
Free Technical Research on Evolus and Three More Generic Drugs EquitiesFree Technical Research on Evolus and Three More Generic Drugs Equities
finance.yahoo.com - July 25 at 8:20 AM
4 Best Performing Biotech Stocks of June: More Room to Run?4 Best Performing Biotech Stocks of June: More Room to Run?
www.nasdaq.com - July 7 at 8:14 AM
Form 424B5 Fibrocell Science, Inc.Form 424B5 Fibrocell Science, Inc.
www.streetinsider.com - July 7 at 8:14 AM
Fibrocell Announces Closing of $4.0 Million Registered Direct OfferingFibrocell Announces Closing of $4.0 Million Registered Direct Offering
finance.yahoo.com - July 5 at 5:04 PM
Fibrocell announces $4M registered direct offering priced at-the-marketFibrocell announces $4M registered direct offering priced at-the-market
seekingalpha.com - July 2 at 4:45 PM
Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-MarketFibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - July 2 at 4:45 PM
Chester County gene therapy company expects $4M direct from direct stock offeringChester County gene therapy company expects $4M direct from direct stock offering
finance.yahoo.com - July 2 at 4:45 PM
Fibrocell Science (FCSC) Sees Hammer Chart Pattern: Time to Buy?Fibrocell Science (FCSC) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - June 1 at 8:26 AM
Chester County gene therapy company completes $6M stock saleChester County gene therapy company completes $6M stock sale
finance.yahoo.com - June 1 at 8:26 AM
Fibrocell Announces Closing of $6.0 Million Registered Direct OfferingFibrocell Announces Closing of $6.0 Million Registered Direct Offering
finance.yahoo.com - May 31 at 5:29 PM
Fibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-MarketFibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - May 29 at 5:18 PM
Fibrocell executes 1:5 reverse splitFibrocell executes 1:5 reverse split
seekingalpha.com - May 25 at 10:31 AM
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Swap

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel